Among patients with annotated PD-L1 staining assessments (224/393 available, 43% missing), 25% had a tumor proportion score (TPS) of less than 1%, 33% had PD-L1 TPS 1–49%, and 42% had PD-L1 TPS ≥ 50%. This evidence concerns the gene CD274 and neoplasm.